nodes	percent_of_prediction	percent_of_DWPC	metapath
Latanoprost—SLC22A1—Cladribine—multiple sclerosis	0.439	1	CbGbCtD
Latanoprost—Macular oedema—Fingolimod—multiple sclerosis	0.0304	0.0738	CcSEcCtD
Latanoprost—Vitreous haemorrhage—Dexamethasone—multiple sclerosis	0.018	0.0438	CcSEcCtD
Latanoprost—Vitreous haemorrhage—Betamethasone—multiple sclerosis	0.018	0.0438	CcSEcCtD
Latanoprost—PTGFR—Small Ligand GPCRs—S1PR1—multiple sclerosis	0.0156	0.104	CbGpPWpGaD
Latanoprost—PTGFR—Prostanoid ligand receptors—PTGER4—multiple sclerosis	0.0144	0.0961	CbGpPWpGaD
Latanoprost—Uveitis—Azathioprine—multiple sclerosis	0.00978	0.0238	CcSEcCtD
Latanoprost—PTGFR—Eicosanoid ligand-binding receptors—PTGER4—multiple sclerosis	0.00954	0.0638	CbGpPWpGaD
Latanoprost—Corneal oedema—Betamethasone—multiple sclerosis	0.00902	0.0219	CcSEcCtD
Latanoprost—Corneal oedema—Dexamethasone—multiple sclerosis	0.00902	0.0219	CcSEcCtD
Latanoprost—PTGFR—Small Ligand GPCRs—PTGER4—multiple sclerosis	0.0079	0.0528	CbGpPWpGaD
Latanoprost—Retinal detachment—Betamethasone—multiple sclerosis	0.00724	0.0176	CcSEcCtD
Latanoprost—Retinal detachment—Dexamethasone—multiple sclerosis	0.00724	0.0176	CcSEcCtD
Latanoprost—Sensation of foreign body—Prednisolone—multiple sclerosis	0.00695	0.0169	CcSEcCtD
Latanoprost—PTGFR—Small Ligand GPCRs—CNR1—multiple sclerosis	0.00685	0.0458	CbGpPWpGaD
Latanoprost—Blepharitis—Cladribine—multiple sclerosis	0.00683	0.0166	CcSEcCtD
Latanoprost—Hyperaemia—Betamethasone—multiple sclerosis	0.00626	0.0152	CcSEcCtD
Latanoprost—Hyperaemia—Dexamethasone—multiple sclerosis	0.00626	0.0152	CcSEcCtD
Latanoprost—Eczema—Fingolimod—multiple sclerosis	0.00599	0.0146	CcSEcCtD
Latanoprost—Eye pain—Fingolimod—multiple sclerosis	0.00596	0.0145	CcSEcCtD
Latanoprost—Sensation of foreign body—Betamethasone—multiple sclerosis	0.0058	0.0141	CcSEcCtD
Latanoprost—Sensation of foreign body—Dexamethasone—multiple sclerosis	0.0058	0.0141	CcSEcCtD
Latanoprost—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—multiple sclerosis	0.0057	0.0381	CbGpPWpGaD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	0.00548	0.0367	CbGpPWpGaD
Latanoprost—Conjunctival hyperaemia—Prednisolone—multiple sclerosis	0.00515	0.0125	CcSEcCtD
Latanoprost—SLCO2B1—Transport of organic anions—ALB—multiple sclerosis	0.00465	0.0311	CbGpPWpGaD
Latanoprost—Bronchitis—Fingolimod—multiple sclerosis	0.00447	0.0109	CcSEcCtD
Latanoprost—PTGFR—GPCRs, Other—S1PR1—multiple sclerosis	0.00446	0.0298	CbGpPWpGaD
Latanoprost—Inflammation—Cladribine—multiple sclerosis	0.00433	0.0105	CcSEcCtD
Latanoprost—Conjunctival hyperaemia—Betamethasone—multiple sclerosis	0.0043	0.0104	CcSEcCtD
Latanoprost—Conjunctival hyperaemia—Dexamethasone—multiple sclerosis	0.0043	0.0104	CcSEcCtD
Latanoprost—Connective tissue disorder—Fingolimod—multiple sclerosis	0.00366	0.00889	CcSEcCtD
Latanoprost—Embolism—Prednisolone—multiple sclerosis	0.00353	0.00858	CcSEcCtD
Latanoprost—Keratitis—Prednisolone—multiple sclerosis	0.00349	0.00849	CcSEcCtD
Latanoprost—Mediastinal disorder—Fingolimod—multiple sclerosis	0.00335	0.00815	CcSEcCtD
Latanoprost—Embolism—Triamcinolone—multiple sclerosis	0.00325	0.00789	CcSEcCtD
Latanoprost—Embolism—Methylprednisolone—multiple sclerosis	0.00324	0.00787	CcSEcCtD
Latanoprost—Back pain—Fingolimod—multiple sclerosis	0.00313	0.00762	CcSEcCtD
Latanoprost—Blepharitis—Betamethasone—multiple sclerosis	0.00307	0.00747	CcSEcCtD
Latanoprost—Blepharitis—Dexamethasone—multiple sclerosis	0.00307	0.00747	CcSEcCtD
Latanoprost—Dermatitis atopic—Prednisolone—multiple sclerosis	0.00306	0.00744	CcSEcCtD
Latanoprost—Vision blurred—Fingolimod—multiple sclerosis	0.00305	0.00742	CcSEcCtD
Latanoprost—Embolism—Dexamethasone—multiple sclerosis	0.00294	0.00716	CcSEcCtD
Latanoprost—Embolism—Betamethasone—multiple sclerosis	0.00294	0.00716	CcSEcCtD
Latanoprost—Keratitis—Betamethasone—multiple sclerosis	0.00291	0.00709	CcSEcCtD
Latanoprost—Keratitis—Dexamethasone—multiple sclerosis	0.00291	0.00709	CcSEcCtD
Latanoprost—Hepatic function abnormal—Azathioprine—multiple sclerosis	0.00284	0.0069	CcSEcCtD
Latanoprost—Dermatitis atopic—Triamcinolone—multiple sclerosis	0.00281	0.00684	CcSEcCtD
Latanoprost—Stinging—Prednisolone—multiple sclerosis	0.0028	0.0068	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Cladribine—multiple sclerosis	0.00275	0.00668	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.00274	0.00666	CcSEcCtD
Latanoprost—Eye irritation—Prednisolone—multiple sclerosis	0.00265	0.00645	CcSEcCtD
Latanoprost—Nervous system disorder—Fingolimod—multiple sclerosis	0.00259	0.0063	CcSEcCtD
Latanoprost—Stinging—Triamcinolone—multiple sclerosis	0.00257	0.00625	CcSEcCtD
Latanoprost—Skin disorder—Fingolimod—multiple sclerosis	0.00257	0.00624	CcSEcCtD
Latanoprost—Embolism—Prednisone—multiple sclerosis	0.00256	0.00623	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Cladribine—multiple sclerosis	0.00245	0.00596	CcSEcCtD
Latanoprost—Dyspnoea—Fingolimod—multiple sclerosis	0.00236	0.00573	CcSEcCtD
Latanoprost—Stinging—Betamethasone—multiple sclerosis	0.00233	0.00567	CcSEcCtD
Latanoprost—Stinging—Dexamethasone—multiple sclerosis	0.00233	0.00567	CcSEcCtD
Latanoprost—Urinary tract infection—Cladribine—multiple sclerosis	0.00228	0.00555	CcSEcCtD
Latanoprost—Conjunctivitis—Cladribine—multiple sclerosis	0.00228	0.00555	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Azathioprine—multiple sclerosis	0.00223	0.00543	CcSEcCtD
Latanoprost—Dermatitis atopic—Prednisone—multiple sclerosis	0.00222	0.00541	CcSEcCtD
Latanoprost—PTGFR—GPCRs, Other—CXCR3—multiple sclerosis	0.00218	0.0146	CbGpPWpGaD
Latanoprost—Embolism—Methotrexate—multiple sclerosis	0.00214	0.00521	CcSEcCtD
Latanoprost—Inflammation—Methylprednisolone—multiple sclerosis	0.00214	0.00521	CcSEcCtD
Latanoprost—Connective tissue disorder—Cladribine—multiple sclerosis	0.00207	0.00504	CcSEcCtD
Latanoprost—PTGFR—G alpha (q) signalling events—GPR65—multiple sclerosis	0.00202	0.0135	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Other—CNR1—multiple sclerosis	0.00196	0.0131	CbGpPWpGaD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00194	0.013	CbGpPWpGaD
Latanoprost—Mediastinal disorder—Cladribine—multiple sclerosis	0.0019	0.00462	CcSEcCtD
Latanoprost—Pruritus—Fingolimod—multiple sclerosis	0.00187	0.00455	CcSEcCtD
Latanoprost—Erythema—Cladribine—multiple sclerosis	0.00184	0.00446	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	0.00181	0.0121	CbGpPWpGaD
Latanoprost—Back pain—Cladribine—multiple sclerosis	0.00178	0.00432	CcSEcCtD
Latanoprost—Dizziness—Fingolimod—multiple sclerosis	0.00175	0.00425	CcSEcCtD
Latanoprost—Dry eye—Dexamethasone—multiple sclerosis	0.00175	0.00424	CcSEcCtD
Latanoprost—Dry eye—Betamethasone—multiple sclerosis	0.00175	0.00424	CcSEcCtD
Latanoprost—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.00172	0.0115	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.00166	0.0111	CbGpPWpGaD
Latanoprost—Headache—Fingolimod—multiple sclerosis	0.00166	0.00403	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Mitoxantrone—multiple sclerosis	0.00161	0.00391	CcSEcCtD
Latanoprost—Arthralgia—Cladribine—multiple sclerosis	0.00156	0.0038	CcSEcCtD
Latanoprost—Chest pain—Cladribine—multiple sclerosis	0.00156	0.0038	CcSEcCtD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.00156	0.0105	CbGpPWpGaD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00155	0.00377	CcSEcCtD
Latanoprost—Mediastinal disorder—Azathioprine—multiple sclerosis	0.00155	0.00376	CcSEcCtD
Latanoprost—Discomfort—Cladribine—multiple sclerosis	0.00154	0.00376	CcSEcCtD
Latanoprost—Eye pain—Dexamethasone—multiple sclerosis	0.00152	0.0037	CcSEcCtD
Latanoprost—Eye pain—Betamethasone—multiple sclerosis	0.00152	0.0037	CcSEcCtD
Latanoprost—Urinary tract infection—Mitoxantrone—multiple sclerosis	0.0015	0.00365	CcSEcCtD
Latanoprost—Conjunctivitis—Mitoxantrone—multiple sclerosis	0.0015	0.00365	CcSEcCtD
Latanoprost—Oedema—Cladribine—multiple sclerosis	0.0015	0.00364	CcSEcCtD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00147	0.00984	CbGpPWpGaD
Latanoprost—Nervous system disorder—Cladribine—multiple sclerosis	0.00147	0.00357	CcSEcCtD
Latanoprost—Skin disorder—Cladribine—multiple sclerosis	0.00146	0.00354	CcSEcCtD
Latanoprost—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.00145	0.0097	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.00143	0.00956	CbGpPWpGaD
Latanoprost—Inflammation—Methotrexate—multiple sclerosis	0.00142	0.00345	CcSEcCtD
Latanoprost—PTGFR—GPCRs, Other—CCR5—multiple sclerosis	0.00137	0.00914	CbGpPWpGaD
Latanoprost—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.00137	0.00332	CcSEcCtD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.00134	0.00895	CbGpPWpGaD
Latanoprost—Dyspnoea—Cladribine—multiple sclerosis	0.00134	0.00325	CcSEcCtD
Latanoprost—Asthma—Triamcinolone—multiple sclerosis	0.00131	0.00318	CcSEcCtD
Latanoprost—Pain—Cladribine—multiple sclerosis	0.00128	0.00312	CcSEcCtD
Latanoprost—Arthralgia—Azathioprine—multiple sclerosis	0.00127	0.00309	CcSEcCtD
Latanoprost—PTGFR—GPCR ligand binding—S1PR1—multiple sclerosis	0.00126	0.00846	CbGpPWpGaD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00126	0.00307	CcSEcCtD
Latanoprost—Bronchitis—Triamcinolone—multiple sclerosis	0.00126	0.00306	CcSEcCtD
Latanoprost—Discomfort—Azathioprine—multiple sclerosis	0.00126	0.00305	CcSEcCtD
Latanoprost—Conjunctivitis—Prednisolone—multiple sclerosis	0.00123	0.00299	CcSEcCtD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00122	0.00819	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00122	0.00819	CbGpPWpGaD
Latanoprost—Upper respiratory tract infection—Triamcinolone—multiple sclerosis	0.00121	0.00295	CcSEcCtD
Latanoprost—Erythema—Mitoxantrone—multiple sclerosis	0.00121	0.00293	CcSEcCtD
Latanoprost—SLC22A1—Neuronal System—KCNA3—multiple sclerosis	0.00119	0.00793	CbGpPWpGaD
Latanoprost—Skin disorder—Azathioprine—multiple sclerosis	0.00118	0.00288	CcSEcCtD
Latanoprost—Back pain—Mitoxantrone—multiple sclerosis	0.00117	0.00284	CcSEcCtD
Latanoprost—Vision blurred—Mitoxantrone—multiple sclerosis	0.00114	0.00277	CcSEcCtD
Latanoprost—Conjunctivitis—Triamcinolone—multiple sclerosis	0.00113	0.00275	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.00111	0.0027	CcSEcCtD
Latanoprost—Pruritus—Cladribine—multiple sclerosis	0.00106	0.00258	CcSEcCtD
Latanoprost—Conjunctivitis—Dexamethasone—multiple sclerosis	0.00103	0.0025	CcSEcCtD
Latanoprost—Conjunctivitis—Betamethasone—multiple sclerosis	0.00103	0.0025	CcSEcCtD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.00103	0.00688	CbGpPWpGaD
Latanoprost—Chest pain—Mitoxantrone—multiple sclerosis	0.00103	0.0025	CcSEcCtD
Latanoprost—Arthralgia—Mitoxantrone—multiple sclerosis	0.00103	0.0025	CcSEcCtD
Latanoprost—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.00103	0.00249	CcSEcCtD
Latanoprost—PTGFR—GPCR ligand binding—GPR65—multiple sclerosis	0.00102	0.00682	CbGpPWpGaD
Latanoprost—Discomfort—Mitoxantrone—multiple sclerosis	0.00102	0.00247	CcSEcCtD
Latanoprost—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00101	0.00678	CbGpPWpGaD
Latanoprost—Dizziness—Cladribine—multiple sclerosis	0.000991	0.00241	CcSEcCtD
Latanoprost—Erythema—Prednisolone—multiple sclerosis	0.00099	0.00241	CcSEcCtD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000986	0.0066	CbGpPWpGaD
Latanoprost—Oedema—Mitoxantrone—multiple sclerosis	0.000985	0.0024	CcSEcCtD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.00098	0.00656	CbGpPWpGaD
Latanoprost—Skin disorder—Mitoxantrone—multiple sclerosis	0.000957	0.00233	CcSEcCtD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000946	0.00633	CbGpPWpGaD
Latanoprost—Rash—Cladribine—multiple sclerosis	0.000945	0.0023	CcSEcCtD
Latanoprost—Dermatitis—Cladribine—multiple sclerosis	0.000944	0.0023	CcSEcCtD
Latanoprost—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000941	0.00229	CcSEcCtD
Latanoprost—Headache—Cladribine—multiple sclerosis	0.000939	0.00228	CcSEcCtD
Latanoprost—Vision blurred—Prednisolone—multiple sclerosis	0.000933	0.00227	CcSEcCtD
Latanoprost—PTGFR—GPCR ligand binding—CXCL13—multiple sclerosis	0.000932	0.00624	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CCR1—multiple sclerosis	0.000932	0.00624	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000921	0.00616	CbGpPWpGaD
Latanoprost—Erythema—Triamcinolone—multiple sclerosis	0.000911	0.00221	CcSEcCtD
Latanoprost—Erythema—Methylprednisolone—multiple sclerosis	0.000909	0.00221	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000899	0.00219	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000898	0.00218	CcSEcCtD
Latanoprost—Back pain—Triamcinolone—multiple sclerosis	0.000881	0.00214	CcSEcCtD
Latanoprost—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000878	0.00214	CcSEcCtD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000872	0.00584	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00087	0.00582	CbGpPWpGaD
Latanoprost—Asthma—Methotrexate—multiple sclerosis	0.000863	0.0021	CcSEcCtD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.00085	0.00568	CbGpPWpGaD
Latanoprost—Pain—Mitoxantrone—multiple sclerosis	0.000843	0.00205	CcSEcCtD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00084	0.00562	CbGpPWpGaD
Latanoprost—Discomfort—Prednisolone—multiple sclerosis	0.000833	0.00203	CcSEcCtD
Latanoprost—Erythema—Betamethasone—multiple sclerosis	0.000826	0.00201	CcSEcCtD
Latanoprost—Erythema—Dexamethasone—multiple sclerosis	0.000826	0.00201	CcSEcCtD
Latanoprost—Connective tissue disorder—Prednisone—multiple sclerosis	0.000812	0.00197	CcSEcCtD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000811	0.00542	CbGpPWpGaD
Latanoprost—Oedema—Prednisolone—multiple sclerosis	0.000808	0.00196	CcSEcCtD
Latanoprost—Dizziness—Azathioprine—multiple sclerosis	0.000806	0.00196	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000802	0.00195	CcSEcCtD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000789	0.00528	CbGpPWpGaD
Latanoprost—Arthralgia—Methylprednisolone—multiple sclerosis	0.000774	0.00188	CcSEcCtD
Latanoprost—Rash—Azathioprine—multiple sclerosis	0.000768	0.00187	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000768	0.00187	CcSEcCtD
Latanoprost—Dermatitis—Azathioprine—multiple sclerosis	0.000768	0.00187	CcSEcCtD
Latanoprost—Discomfort—Triamcinolone—multiple sclerosis	0.000766	0.00186	CcSEcCtD
Latanoprost—Discomfort—Methylprednisolone—multiple sclerosis	0.000764	0.00186	CcSEcCtD
Latanoprost—Headache—Azathioprine—multiple sclerosis	0.000764	0.00186	CcSEcCtD
Latanoprost—Conjunctivitis—Methotrexate—multiple sclerosis	0.000748	0.00182	CcSEcCtD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000747	0.005	CbGpPWpGaD
Latanoprost—Oedema—Triamcinolone—multiple sclerosis	0.000743	0.00181	CcSEcCtD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000728	0.00487	CbGpPWpGaD
Latanoprost—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000727	0.00177	CcSEcCtD
Latanoprost—Skin disorder—Methylprednisolone—multiple sclerosis	0.00072	0.00175	CcSEcCtD
Latanoprost—Erythema—Prednisone—multiple sclerosis	0.00072	0.00175	CcSEcCtD
Latanoprost—PTGFR—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000715	0.00478	CbGpPWpGaD
Latanoprost—Discomfort—Betamethasone—multiple sclerosis	0.000695	0.00169	CcSEcCtD
Latanoprost—Discomfort—Dexamethasone—multiple sclerosis	0.000695	0.00169	CcSEcCtD
Latanoprost—Pain—Prednisolone—multiple sclerosis	0.000691	0.00168	CcSEcCtD
Latanoprost—Vision blurred—Prednisone—multiple sclerosis	0.000678	0.00165	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000677	0.00165	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000676	0.00164	CcSEcCtD
Latanoprost—Oedema—Dexamethasone—multiple sclerosis	0.000674	0.00164	CcSEcCtD
Latanoprost—Oedema—Betamethasone—multiple sclerosis	0.000674	0.00164	CcSEcCtD
Latanoprost—PTGFR—GPCR ligand binding—CCL3—multiple sclerosis	0.000664	0.00444	CbGpPWpGaD
Latanoprost—Dyspnoea—Triamcinolone—multiple sclerosis	0.000663	0.00161	CcSEcCtD
Latanoprost—Nervous system disorder—Betamethasone—multiple sclerosis	0.000661	0.00161	CcSEcCtD
Latanoprost—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000661	0.00161	CcSEcCtD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000659	0.00441	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000655	0.00438	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—S1PR1—multiple sclerosis	0.000649	0.00434	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—PTGER4—multiple sclerosis	0.000639	0.00428	CbGpPWpGaD
Latanoprost—Pain—Triamcinolone—multiple sclerosis	0.000636	0.00155	CcSEcCtD
Latanoprost—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000623	0.00151	CcSEcCtD
Latanoprost—Rash—Mitoxantrone—multiple sclerosis	0.000621	0.00151	CcSEcCtD
Latanoprost—Dermatitis—Mitoxantrone—multiple sclerosis	0.000621	0.00151	CcSEcCtD
Latanoprost—PTGFR—GPCR ligand binding—CXCR3—multiple sclerosis	0.000618	0.00413	CbGpPWpGaD
Latanoprost—Headache—Mitoxantrone—multiple sclerosis	0.000617	0.0015	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000614	0.00149	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000614	0.00149	CcSEcCtD
Latanoprost—Arthralgia—Prednisone—multiple sclerosis	0.000613	0.00149	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000608	0.00148	CcSEcCtD
Latanoprost—PTGFR—GPCR downstream signaling—RGS1—multiple sclerosis	0.000608	0.00406	CbGpPWpGaD
Latanoprost—Discomfort—Prednisone—multiple sclerosis	0.000605	0.00147	CcSEcCtD
Latanoprost—Erythema—Methotrexate—multiple sclerosis	0.000601	0.00146	CcSEcCtD
Latanoprost—PTGFR—GPCR ligand binding—CCR2—multiple sclerosis	0.000601	0.00402	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000593	0.00397	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000591	0.00395	CbGpPWpGaD
Latanoprost—Oedema—Prednisone—multiple sclerosis	0.000587	0.00143	CcSEcCtD
Latanoprost—Back pain—Methotrexate—multiple sclerosis	0.000582	0.00141	CcSEcCtD
Latanoprost—Pain—Dexamethasone—multiple sclerosis	0.000577	0.0014	CcSEcCtD
Latanoprost—Pain—Betamethasone—multiple sclerosis	0.000577	0.0014	CcSEcCtD
Latanoprost—Nervous system disorder—Prednisone—multiple sclerosis	0.000576	0.0014	CcSEcCtD
Latanoprost—PTGFR—GPCR downstream signaling—GPR65—multiple sclerosis	0.000576	0.00385	CbGpPWpGaD
Latanoprost—Skin disorder—Prednisone—multiple sclerosis	0.000571	0.00139	CcSEcCtD
Latanoprost—Vision blurred—Methotrexate—multiple sclerosis	0.000567	0.00138	CcSEcCtD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000564	0.00377	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CNR1—multiple sclerosis	0.000554	0.00371	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—RGS1—multiple sclerosis	0.000552	0.00369	CbGpPWpGaD
Latanoprost—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000535	0.0013	CcSEcCtD
Latanoprost—Dizziness—Prednisolone—multiple sclerosis	0.000535	0.0013	CcSEcCtD
Latanoprost—PTGFR—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000527	0.00352	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CCR1—multiple sclerosis	0.000527	0.00352	CbGpPWpGaD
Latanoprost—Pruritus—Triamcinolone—multiple sclerosis	0.000526	0.00128	CcSEcCtD
Latanoprost—Pruritus—Methylprednisolone—multiple sclerosis	0.000525	0.00128	CcSEcCtD
Latanoprost—PTGFR—Signaling by GPCR—GPR65—multiple sclerosis	0.000523	0.0035	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000522	0.00349	CbGpPWpGaD
Latanoprost—Chest pain—Methotrexate—multiple sclerosis	0.000512	0.00124	CcSEcCtD
Latanoprost—Arthralgia—Methotrexate—multiple sclerosis	0.000512	0.00124	CcSEcCtD
Latanoprost—Rash—Prednisolone—multiple sclerosis	0.00051	0.00124	CcSEcCtD
Latanoprost—Dermatitis—Prednisolone—multiple sclerosis	0.000509	0.00124	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000509	0.00124	CcSEcCtD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000508	0.0034	CbGpPWpGaD
Latanoprost—Headache—Prednisolone—multiple sclerosis	0.000506	0.00123	CcSEcCtD
Latanoprost—Discomfort—Methotrexate—multiple sclerosis	0.000506	0.00123	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—LINGO1—multiple sclerosis	0.000506	0.00338	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CXCL10—multiple sclerosis	0.000499	0.00334	CbGpPWpGaD
Latanoprost—Dizziness—Triamcinolone—multiple sclerosis	0.000492	0.00119	CcSEcCtD
Latanoprost—Dizziness—Methylprednisolone—multiple sclerosis	0.00049	0.00119	CcSEcCtD
Latanoprost—Nervous system disorder—Methotrexate—multiple sclerosis	0.000481	0.00117	CcSEcCtD
Latanoprost—PTGFR—Signaling by GPCR—CCR1—multiple sclerosis	0.000478	0.0032	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CXCL13—multiple sclerosis	0.000478	0.0032	CbGpPWpGaD
Latanoprost—Pruritus—Betamethasone—multiple sclerosis	0.000477	0.00116	CcSEcCtD
Latanoprost—Pruritus—Dexamethasone—multiple sclerosis	0.000477	0.00116	CcSEcCtD
Latanoprost—Skin disorder—Methotrexate—multiple sclerosis	0.000477	0.00116	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000477	0.00319	CbGpPWpGaD
Latanoprost—Rash—Triamcinolone—multiple sclerosis	0.000469	0.00114	CcSEcCtD
Latanoprost—Dermatitis—Triamcinolone—multiple sclerosis	0.000468	0.00114	CcSEcCtD
Latanoprost—Rash—Methylprednisolone—multiple sclerosis	0.000468	0.00114	CcSEcCtD
Latanoprost—Dermatitis—Methylprednisolone—multiple sclerosis	0.000467	0.00114	CcSEcCtD
Latanoprost—Headache—Triamcinolone—multiple sclerosis	0.000466	0.00113	CcSEcCtD
Latanoprost—Headache—Methylprednisolone—multiple sclerosis	0.000465	0.00113	CcSEcCtD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000461	0.00308	CbGpPWpGaD
Latanoprost—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000447	0.00109	CcSEcCtD
Latanoprost—Dizziness—Dexamethasone—multiple sclerosis	0.000446	0.00108	CcSEcCtD
Latanoprost—Dizziness—Betamethasone—multiple sclerosis	0.000446	0.00108	CcSEcCtD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000442	0.00296	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TAGAP—multiple sclerosis	0.000439	0.00293	CbGpPWpGaD
Latanoprost—Dyspnoea—Methotrexate—multiple sclerosis	0.000438	0.00106	CcSEcCtD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000434	0.0029	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CCL5—multiple sclerosis	0.00043	0.00287	CbGpPWpGaD
Latanoprost—Rash—Dexamethasone—multiple sclerosis	0.000425	0.00103	CcSEcCtD
Latanoprost—Rash—Betamethasone—multiple sclerosis	0.000425	0.00103	CcSEcCtD
Latanoprost—Dermatitis—Betamethasone—multiple sclerosis	0.000425	0.00103	CcSEcCtD
Latanoprost—Dermatitis—Dexamethasone—multiple sclerosis	0.000425	0.00103	CcSEcCtD
Latanoprost—Headache—Dexamethasone—multiple sclerosis	0.000423	0.00103	CcSEcCtD
Latanoprost—Headache—Betamethasone—multiple sclerosis	0.000423	0.00103	CcSEcCtD
Latanoprost—Pain—Methotrexate—multiple sclerosis	0.00042	0.00102	CcSEcCtD
Latanoprost—Pruritus—Prednisone—multiple sclerosis	0.000416	0.00101	CcSEcCtD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000397	0.00266	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000389	0.0026	CbGpPWpGaD
Latanoprost—Dizziness—Prednisone—multiple sclerosis	0.000388	0.000944	CcSEcCtD
Latanoprost—PTGFR—GPCR ligand binding—CCR5—multiple sclerosis	0.000387	0.00259	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—S1PR1—multiple sclerosis	0.000383	0.00256	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GPC5—multiple sclerosis	0.000373	0.00249	CbGpPWpGaD
Latanoprost—Rash—Prednisone—multiple sclerosis	0.00037	0.0009	CcSEcCtD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.00037	0.00248	CbGpPWpGaD
Latanoprost—Dermatitis—Prednisone—multiple sclerosis	0.00037	0.000899	CcSEcCtD
Latanoprost—Headache—Prednisone—multiple sclerosis	0.000368	0.000895	CcSEcCtD
Latanoprost—PTGFR—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000361	0.00242	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000349	0.00233	CbGpPWpGaD
Latanoprost—Pruritus—Methotrexate—multiple sclerosis	0.000347	0.000844	CcSEcCtD
Latanoprost—PTGFR—Signaling by GPCR—CCL3—multiple sclerosis	0.000341	0.00228	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CCR2—multiple sclerosis	0.000339	0.00227	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000335	0.00224	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—BCHE—multiple sclerosis	0.000333	0.00223	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PTGER4—multiple sclerosis	0.000328	0.0022	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—RGS1—multiple sclerosis	0.000326	0.00218	CbGpPWpGaD
Latanoprost—Dizziness—Methotrexate—multiple sclerosis	0.000325	0.000789	CcSEcCtD
Latanoprost—PTGFR—Signaling by GPCR—CXCR3—multiple sclerosis	0.000317	0.00212	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CNR1—multiple sclerosis	0.000313	0.0021	CbGpPWpGaD
Latanoprost—Rash—Methotrexate—multiple sclerosis	0.00031	0.000752	CcSEcCtD
Latanoprost—Dermatitis—Methotrexate—multiple sclerosis	0.000309	0.000752	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—GPR65—multiple sclerosis	0.000309	0.00207	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CCR2—multiple sclerosis	0.000308	0.00206	CbGpPWpGaD
Latanoprost—Headache—Methotrexate—multiple sclerosis	0.000308	0.000748	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000303	0.00203	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—POMC—multiple sclerosis	0.000303	0.00202	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CCL2—multiple sclerosis	0.000296	0.00198	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CNR1—multiple sclerosis	0.000284	0.0019	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CXCL13—multiple sclerosis	0.000283	0.00189	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCR1—multiple sclerosis	0.000283	0.00189	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000282	0.00189	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SRM—multiple sclerosis	0.000273	0.00183	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000265	0.00177	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CXCL10—multiple sclerosis	0.000256	0.00171	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CCL5—multiple sclerosis	0.000243	0.00162	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000234	0.00157	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000233	0.00156	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CCL5—multiple sclerosis	0.000221	0.00148	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CCR5—multiple sclerosis	0.000219	0.00146	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000216	0.00144	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCL3—multiple sclerosis	0.000201	0.00135	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CCR5—multiple sclerosis	0.000199	0.00133	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL2RA—multiple sclerosis	0.000196	0.00131	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PTGER4—multiple sclerosis	0.000194	0.0013	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP27B1—multiple sclerosis	0.000192	0.00129	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP24A1—multiple sclerosis	0.000192	0.00129	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PGR—multiple sclerosis	0.000191	0.00128	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000188	0.00126	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CXCR3—multiple sclerosis	0.000187	0.00125	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CD28—multiple sclerosis	0.000185	0.00124	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCR2—multiple sclerosis	0.000182	0.00122	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GPC5—multiple sclerosis	0.000176	0.00118	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—POMC—multiple sclerosis	0.000171	0.00114	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CNR1—multiple sclerosis	0.000168	0.00112	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000166	0.00111	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—POMC—multiple sclerosis	0.000155	0.00104	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CCL2—multiple sclerosis	0.000152	0.00102	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CXCL10—multiple sclerosis	0.000151	0.00101	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—RRM1—multiple sclerosis	0.000146	0.000976	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—TYK2—multiple sclerosis	0.000138	0.000923	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CD86—multiple sclerosis	0.000132	0.000885	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCL5—multiple sclerosis	0.00013	0.000871	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000127	0.000849	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—IL2—multiple sclerosis	0.000126	0.000846	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SPP1—multiple sclerosis	0.000121	0.000807	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCR5—multiple sclerosis	0.000117	0.000785	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL2RA—multiple sclerosis	0.000116	0.000774	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL2—multiple sclerosis	0.000115	0.000768	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APOE—multiple sclerosis	0.000107	0.000714	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—MAPK1—multiple sclerosis	9.72e-05	0.00065	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CD80—multiple sclerosis	9.65e-05	0.000646	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—POMC—multiple sclerosis	9.17e-05	0.000614	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCL2—multiple sclerosis	8.97e-05	0.0006	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—MAPK1—multiple sclerosis	8.78e-05	0.000587	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.43e-05	0.000564	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—BCHE—multiple sclerosis	8.38e-05	0.00056	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TYK2—multiple sclerosis	8.15e-05	0.000545	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL2—multiple sclerosis	6.78e-05	0.000454	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL6—multiple sclerosis	6.75e-05	0.000451	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MMP9—multiple sclerosis	6.42e-05	0.000429	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—STAT3—multiple sclerosis	5.71e-05	0.000382	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MYC—multiple sclerosis	5.3e-05	0.000355	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TGFB1—multiple sclerosis	5.29e-05	0.000354	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MAPK1—multiple sclerosis	5.19e-05	0.000347	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—APOE—multiple sclerosis	5.04e-05	0.000337	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—POMC—multiple sclerosis	4.33e-05	0.00029	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL6—multiple sclerosis	3.99e-05	0.000267	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALB—multiple sclerosis	3.95e-05	0.000264	CbGpPWpGaD
